Key result
Medical management of primary endocardial fibroelastosis yielded a 56% long-term survival rate and 44% mortality, with 27 of 31 survivors free of cardiac symptoms or cardiomegaly.
Medical management of primary endocardial fibroelastosis is associated with a 56% long-term survival rate, with the majority of survivors remaining free of cardiac symptoms or cardiomegaly.
Answers are grounded in this paper and cite their sources.
Supports medical management for primary endocardial fibroelastosis; observational data leave open need for prospective trials before changing practice.
Fifty-six patients with the clinical diagnosis of primary endocardial fibroelastosis have been reviewed. There was an over-all mortality rate of 44 per cent and a long-term survival of 56 per cent. Of 31 long-term survivors, 27 are without cardiac symptomatology or cardiomegaly. The method and rationale of therapy are reviewed.
No takes yet. Share an insight, caveat, or question.
Manning et al. (1964) studied this question. Medical management of primary endocardial fibroelastosis yielded a 56% long-term survival rate and 44% mortality, with 27 of 31 survivors free of cardiac symptoms or cardiomegaly.
Synapse has enriched 10 related papers. Consider them for comparative context: